latest

Ten new tech start-ups chosen for accelerator programme

23rd November 2020 about a 3 minute read

KQ Labs has announced ten new tech start-ups to take part in its third annual programme aimed at supporting projects that will have a major positive impact on health.

The selected start-ups will join a five-month scheme which will include mentoring with experts and opportunities for discussions with investors and potential partners. 

The projects include new digital technology to help people who stutter, women with endometriosis, developmental support for children through mobile games and smart toys, and a wearable device to help people with Parkinson’s.

Demo day will showcase projects

At the end of the programme in March those taking part will be able to pitch their proposals to potential investors and partners at a ‘demo day.’

KQ Labs is an accelerator programme for start-ups in data-driven health. It is run by the Francis Crick Institute and is now funded by the medical research charity LifeArc.

Veronique Birault, Director of Translation at the Crick Institute, commented: “With many experienced, world-leading experts in our network offering guidance and training as part of KQ Labs, we hope to help these start-ups to develop into exciting companies that can deliver better treatments or improved quality of life for patients across the globe.”

The start-ups taking part in the latest cohort are:

  • AI VIVO combines systems biology and machine learning/AI to build a disruptive platform technology to accelerate drug discovery.
  • Benetalk has developed a digital speech therapist that monitors speaking patterns and provides immediate feedback to help people who stutter
  • Brightlobe develops cutting-edge technology that can assess and support a child’s development through mobile games and smart toys.
  • Charco Neurotech has developed a wearable device for Parkinson’s which uses pulsed cueing and focused vibrotactile stimulation to reduce symptoms of slowness and stiffness.
  • GLAMOROUS AI Its proprietary platform, Rosalind, augments advanced machine learning with human expertise to enable applications where only limited data points are available.
  • Itecho Health provides digital health applications and services for the monitoring and management of long-term conditions.
  • Mpixl combines deep learning and MRI radiology for faster and kinder care of leukaemia patients.
  • Little Journey uses technology, research and data to transform healthcare and research outcomes through an end to end psychological preparation and support tool for children and their families.
  • Oxford Cancer Analytics aims to revolutionise early cancer detection and treatment through affordable blood tests using automated machine learning platforms for data analysis, biomarker discovery and patient stratification.
  • Syrona is a personalised digital women’s health screening and digital therapeutics platform. Its first focus is endometriosis.